Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.7K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.7K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

810
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
810
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

984
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
984
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

3.0K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel two-hit murine model of inhaled occupational exposure-induced lung disease.

Physiological reports·2026
Same author

Short-Term Open-Field Testing Reveals Sex- and Age-Dependent Behavioral Patterns in Mice.

Journal of aging & related diseases·2026
Same author

Dose-Dependent Efficacy of a Riboflavin and Ultraviolet Light-Inactivated Whole-Virion SARS-CoV-2 Vaccine in a Hamster Infection Challenge Model.

Vaccines·2026
Same author

B cells and iBALT in TB immunity & pathogenesis.

Frontiers in immunology·2026
Same author

A Review of Rodent Behavior, Mobility, and Pain Modifications in Response to Destabilization of the Medial Meniscus Injury.

Biomedicines·2025
Same author

Blood pro-thrombotic analytes and platelet activation are associated with post-acute sequelae of COVID-19.

BMC infectious diseases·2025

Related Experiment Video

Updated: Apr 27, 2026

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
15:57

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

13.8K

Memory T cell subsets in tuberculosis: what should we be targeting?

Marcela Henao-Tamayo1, Diane J Ordway1, Ian M Orme1

  • 1Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.

Tuberculosis (Edinburgh, Scotland)
|July 5, 2014
PubMed
Summary

Vaccination aims to create long-lived memory T cells. For tuberculosis, the BCG vaccine is less effective in adults, highlighting the need to understand T cell subsets for improved TB vaccines.

Keywords:
Memory T cellsTuberculosisVaccination

More Related Videos

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
11:17

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

Published on: August 11, 2018

13.8K
Enzyme-linked Immunospot Assay ELISPOT: Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens
06:13

Enzyme-linked Immunospot Assay ELISPOT: Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens

Published on: November 23, 2010

34.3K

Related Experiment Videos

Last Updated: Apr 27, 2026

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
15:57

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

13.8K
A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
11:17

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

Published on: August 11, 2018

13.8K
Enzyme-linked Immunospot Assay ELISPOT: Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens
06:13

Enzyme-linked Immunospot Assay ELISPOT: Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens

Published on: November 23, 2010

34.3K

Area of Science:

  • Immunology
  • Vaccinology
  • Tuberculosis Research

Background:

  • The Bacillus Calmette-Guérin (BCG) vaccine has been used for tuberculosis (TB) for over 60 years.
  • BCG's limitations, especially its ineffectiveness in adults, are increasingly recognized.
  • Understanding memory T cell responses is crucial for developing effective TB vaccines.

Purpose of the Study:

  • To review current knowledge on memory T cells in the context of acquired resistance to tuberculosis.
  • To discuss the predominant T cell subsets generated by vaccination and their implications for new TB vaccine development.

Main Methods:

  • Review of existing literature on memory T cells and tuberculosis immunity.
  • Analysis of findings from animal models and clinical studies on T cell responses to TB vaccines.

Main Results:

  • Both effector memory and central memory T cells can be generated, with effector memory T cells being the predominant subset.
  • The role of specific T cell subsets in conferring resistance to tuberculosis is complex and not fully understood.
  • Emerging evidence suggests other T cell subsets, including IL-17 secreting CD4 T cells and stem cell-like T cells, may also be important.

Conclusions:

  • Effector memory T cells are the main subset generated in response to TB vaccination, but their precise role in protection requires further investigation.
  • The optimal T cell subset(s) to target for new TB vaccines remains unknown.
  • Future TB vaccine strategies may need to consider a broader range of T cell populations, including IL-17 secreting CD4 T cells and stem cell-like T cells.